Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 98 articles:
HTML format
Text format



Single Articles


    November 2018
  1. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
    Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
    PubMed     Text format     Abstract available


  2. WANG X, Li M, Lin Z, Pan H, et al
    Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31486.
    PubMed     Text format     Abstract available


    October 2018
  3. LOPEZ-GATELL H, Garcia-Garcia L, Echaniz-Aviles G, Cruz-Hervert P, et al
    Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31403.
    PubMed     Text format     Abstract available


    September 2018
  4. BARTHOLOMEUS E, De Neuter N, Meysman P, Suls A, et al
    Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
    Vaccine. 2018 Sep 8. pii: S0264-410X(18)31236.
    PubMed     Text format     Abstract available


  5. GROOM HC, Irving SA, Koppolu P, Smith N, et al
    Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31214.
    PubMed     Text format     Abstract available


    August 2018
  6. OBANDO-PACHECO P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, et al
    New perspectives for hexavalent vaccines.
    Vaccine. 2018;36:5485-5494.
    PubMed     Text format     Abstract available


  7. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31167.
    PubMed     Text format     Abstract available


  8. PHAM TT, Le HM, Nguyen DT, Maertens K, et al
    Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31109.
    PubMed     Text format     Abstract available


  9. ELWOOD JM, Ameratunga R
    Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).
    Vaccine. 2018 Aug 9. pii: S0264-410X(18)31094.
    PubMed     Text format     Abstract available


  10. DOBRICA MO, Lazar C, Paruch L, van Eerde A, et al
    Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Vaccine. 2018 Aug 3. pii: S0264-410X(18)31081.
    PubMed     Text format     Abstract available


    July 2018
  11. RAVEN S, Urbanus A, de Gee A, Hoebe C, et al
    Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31014.
    PubMed     Text format     Abstract available


  12. SAITOH A, Okabe N
    Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap".
    Vaccine. 2018;36:4582-4588.
    PubMed     Text format     Abstract available


    June 2018
  13. AUTA A, Adewuyi EO, Kureh GT, Onoviran N, et al
    Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis.
    Vaccine. 2018 Jun 30. pii: S0264-410X(18)30871.
    PubMed     Text format     Abstract available


  14. HECHTER RC, Qian L, Luo Y, Ling Grant DS, et al
    Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.
    Vaccine. 2018 Jun 26. pii: S0264-410X(18)30863.
    PubMed     Text format     Abstract available


  15. BOHM K, Krause G, Sievers C
    Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2018;36:3885.
    PubMed     Text format    


  16. HERZOG C, Mayorga O
    Serologic differential diagnosis of hepatitis A virus (HAV) infected and vaccinated individuals: How long persist antibodies to non-structural HAV proteins?
    Vaccine. 2018;36:3883-3884.
    PubMed     Text format    


  17. GILLAM F, Zhang C
    Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen.
    Vaccine. 2018 Jun 15. pii: S0264-410X(18)30831.
    PubMed     Text format     Abstract available


  18. TRANTHAM L, Kurosky SK, Zhang D, Johnson KD, et al
    Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30788.
    PubMed     Text format     Abstract available


  19. FOUGERE Y, El Houss S, Suris JC, Rouvenaz-Defago S, et al
    High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30825.
    PubMed     Text format     Abstract available


  20. RUSSO R, Bozzola E, Villani A
    Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30794.
    PubMed     Text format    


    May 2018
  21. LIU X, Yang C, Zhong Q, Song Q, et al
    Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011-2016.
    Vaccine. 2018 May 26. pii: S0264-410X(18)30751.
    PubMed     Text format     Abstract available


  22. CHUAI X, Xie B, Chen H, Tan X, et al
    The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
    PubMed     Text format     Abstract available


  23. HIRSH BAR GAI D, Graybill Z, Voevodsky P, Shittu E, et al
    Evaluating scenarios of locations and capacities for vaccine storage in Nigeria.
    Vaccine. 2018 May 14. pii: S0264-410X(18)30579.
    PubMed     Text format     Abstract available


  24. CHEAH BC, Davies J, Singh GR, Wood N, et al
    Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30122.
    PubMed     Text format     Abstract available


  25. BREDBERG A, Boe OW, Bredberg J, Whist JE, et al
    Detection of hepatitis B surface antigen in blood following vaccination.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30600.
    PubMed     Text format    


    April 2018
  26. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged >/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30376.
    PubMed     Text format     Abstract available


  27. REEKIE J, Kaldor JM, Mak DB, Ward J, et al
    Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30554.
    PubMed     Text format     Abstract available


  28. LINK-GELLES R, Hofmeister MG, Nelson NP
    Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40years of age: A systematic review of published studies and recommendations for vaccine use.
    Vaccine. 2018 Apr 16. pii: S0264-410X(18)30484.
    PubMed     Text format     Abstract available


  29. TAVOSCHI L, Severi E, Carrillo Santisteve P, Lopalco P, et al
    Hepatitis A in the EU/EEA: The case for scaling up prevention.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30299.
    PubMed     Text format    


  30. HYER R, McGuire DK, Xing B, Jackson S, et al
    Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30436.
    PubMed     Text format     Abstract available


    March 2018
  31. GARCIA D, Porras A, Rico Mendoza A, Alvis N, et al
    Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Vaccine. 2018 Mar 30. pii: S0264-410X(17)31546.
    PubMed     Text format     Abstract available


  32. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged>/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30375.
    PubMed     Text format     Abstract available


  33. LI X, Xu Y, Dong Y, Yang X, et al
    Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Vaccine. 2018 Mar 24. pii: S0264-410X(18)30389.
    PubMed     Text format     Abstract available


  34. WEI S, Lei Y, Yang J, Wang X, et al
    Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
    PubMed     Text format     Abstract available


  35. KLINGER G, Chodick G, Levy I
    Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373.
    PubMed     Text format     Abstract available


  36. LIU Y, Ma C, Jia H, Xu E, et al
    Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30354.
    PubMed     Text format     Abstract available


  37. ZHANG L, Yan B, Lv J, Liu J, et al
    Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30213.
    PubMed     Text format     Abstract available


  38. ZHENG M, Jiang J, Zhang X, Wang N, et al
    Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30341.
    PubMed     Text format     Abstract available


  39. SALAMA II, Sami SM, Said ZN, Salama SI, et al
    Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Vaccine. 2018 Mar 9. pii: S0264-410X(18)30313.
    PubMed     Text format     Abstract available


    February 2018
  40. YUE X, Black CL, O'Halloran A, Lu PJ, et al
    Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
    Vaccine. 2018;36:1183-1189.
    PubMed     Text format     Abstract available


  41. WANG D, Zhang Y, Ma C, Ma D, et al
    Live recombinant Lactococcuslactis expressing avian hepatitis virus ORF2 protein: Immunoprotection against homologous virus challenge in chickens.
    Vaccine. 2018;36:1108-1115.
    PubMed     Text format     Abstract available


  42. MOUCHET J, Salvo F, Raschi E, Poluzzi E, et al
    Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30210.
    PubMed     Text format     Abstract available


  43. FREIDL GS, Tostmann A, Curvers M, Ruijs WLM, et al
    Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30152.
    PubMed     Text format     Abstract available


  44. KOURKOUNTI S, Retsas T, Paparizos V, Tsimpidakis A, et al
    Evaluation of a convenient vaccination schedule against hepatitis B in HIV-patients with undetectable HIV viral load.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30192.
    PubMed     Text format     Abstract available


  45. NELSON NP, Yankey D, Singleton JA, Elam-Evans LD, et al
    Hepatitis A vaccination coverage among adolescents (13-17years) in the United States, 2008-2016.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30163.
    PubMed     Text format     Abstract available


  46. SUN X, Wang F, Zheng H, Miao N, et al
    The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Vaccine. 2018 Feb 1. pii: S0264-410X(18)30092.
    PubMed     Text format     Abstract available


  47. YI X, Yuan Y, Li N, Yi L, et al
    A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Vaccine. 2018;36:794-801.
    PubMed     Text format     Abstract available


    January 2018
  48. OMENACA F, Vazquez L, Garcia-Corbeira P, Mesaros N, et al
    Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
    Vaccine. 2018 Jan 11. pii: S0264-410X(18)30029.
    PubMed     Text format     Abstract available


  49. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Text format     Abstract available


    December 2017
  50. GUPTA A, Popowich S, Ojkic D, Kurukulasuriya S, et al
    Inactivated and live bivalent fowl adenovirus (FAdV8b+FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31808.
    PubMed     Text format     Abstract available


  51. JACKSON S, Lentino J, Kopp J, Murray L, et al
    Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791.
    PubMed     Text format     Abstract available


  52. SHIVE CL, Judge CJ, Clagett B, Kalayjian RC, et al
    Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31761.
    PubMed     Text format     Abstract available


  53. HABER P, Moro PL, Ng C, Lewis PW, et al
    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31722.
    PubMed     Text format     Abstract available


  54. VON DELFT A, Donnison TA, Lourenco J, Hutchings C, et al
    The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
    Vaccine. 2017 Dec 1. pii: S0264-410X(17)31487.
    PubMed     Text format     Abstract available


    November 2017
  55. WEI KP, Zhu FC, Liu JX, Yan L, et al
    The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Vaccine. 2017 Nov 28. pii: S0264-410X(17)31601.
    PubMed     Text format     Abstract available


  56. CHEN Y, Zhou CL, Zhang XJ, Hao ZY, et al
    Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
    Vaccine. 2017 Nov 25. pii: S0264-410X(17)31600.
    PubMed     Text format     Abstract available


  57. MORO PL, Zheteyeva Y, Barash F, Lewis P, et al
    Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31603.
    PubMed     Text format     Abstract available


  58. CHILDS L, Roesel S, Tohme RA
    Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31591.
    PubMed     Text format     Abstract available


  59. PETIT D, Tevi-Benissan C, Woodring J, Hennessey K, et al
    Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31421.
    PubMed     Text format     Abstract available


  60. HUO C, Yang J, Lei L, Qiao L, et al
    Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31530.
    PubMed     Text format     Abstract available


    October 2017
  61. LANDI A, Law J, Hockman D, Logan M, et al
    Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31480.
    PubMed     Text format     Abstract available


  62. LU Y, Zhu FC, Liu JX, Zhai XJ, et al
    The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31428.
    PubMed     Text format     Abstract available


  63. WANG J, Qiu J, Zhu Y, Zhou H, et al
    Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Vaccine. 2017;35:5808-5813.
    PubMed     Text format     Abstract available


  64. FUKUSHIMA S, Kiyohara T, Ishii K, Nakano T, et al
    Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix(R)) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen(R)) for Japanese travelers to endemic countries.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31357.
    PubMed     Text format     Abstract available


  65. PILEGGI C, Papadopoli R, Bianco A, Pavia M, et al
    Hepatitis B vaccine and the need for a booster dose after primary vaccination.
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31329.
    PubMed     Text format     Abstract available


    September 2017
  66. BOHM K, Filomena A, Schneiderhan-Marra N, Krause G, et al
    Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31189.
    PubMed     Text format     Abstract available


  67. OKADA Y, Uno N, Sato S, Mori S, et al
    Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population.
    Vaccine. 2017 Sep 4. pii: S0264-410X(17)31133.
    PubMed     Text format     Abstract available


    August 2017
  68. JAYASUNDARA D, Hui BB, Regan DG, Heywood AE, et al
    Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia.
    Vaccine. 2017 Aug 17. pii: S0264-410X(17)31089.
    PubMed     Text format     Abstract available


  69. CAO YF, Tao H, Hu YM, Shi CB, et al
    A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
    Vaccine. 2017 Aug 10. pii: S0264-410X(17)30731.
    PubMed     Text format     Abstract available


  70. SCHLAUD M, Schmitz R, Poethko-Muller C, Kuhnert R, et al
    Vaccinations in the first year of life and risk of atopic disease - Results from the KiGGS study.
    Vaccine. 2017 Aug 8. pii: S0264-410X(17)31062.
    PubMed     Text format     Abstract available


  71. CADAVID-BETANCUR DA, Ospina MC, Hincapie-Palacio D, Bernal-Restrepo LM, et al
    Seroprevalence of hepatitis B and factors potentially associated in a population-based study in Medellin, Colombia.
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)31010.
    PubMed     Text format     Abstract available


    July 2017
  72. HE H, Zhou Y, Xie S
    Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    Vaccine. 2017 Jul 24. pii: S0264-410X(17)30947.
    PubMed     Text format     Abstract available


  73. WORLD HEALTH ORGANIZATION
    Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
    Vaccine. 2017 Jul 22. pii: S0264-410X(17)30954.
    PubMed     Text format     Abstract available


  74. PATEL DP, Treat JR, Castelo-Socio L
    Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30933.
    PubMed     Text format     Abstract available


  75. HUYNH C, Minuk GY, Uhanova J, Baikie M, et al
    Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30948.
    PubMed     Text format     Abstract available


  76. LI X, Heffelfinger J, Wiesen E, Diorditsa S, et al
    Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education.
    Vaccine. 2017 Jul 5. pii: S0264-410X(17)30853.
    PubMed     Text format     Abstract available


  77. ZHOU Y, He H, Deng X, Yan R, et al
    Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Vaccine. 2017 Jul 4. pii: S0264-410X(17)30875.
    PubMed     Text format     Abstract available


    June 2017
  78. LARA AN, Sartori AM, Fonseca MO, Lopes MH, et al
    Long-term protection after hepatitis B vaccination in people living with HIV.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30827.
    PubMed     Text format     Abstract available


  79. ALLISON RD, Patel MK, Tohme RA
    Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30848.
    PubMed     Text format     Abstract available


  80. WANG F, Zhang G, Zheng H, Miao N, et al
    Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Vaccine. 2017 Jun 23. pii: S0264-410X(17)30796.
    PubMed     Text format     Abstract available


  81. ZANETTI A, Desole MG, Romano L, d'Alessandro A, et al
    Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30683.
    PubMed     Text format     Abstract available


  82. RAMIREZ-SOTO MC, Ortega-Caceres G, Cabezas C
    Trends in mortality burden of hepatocellular carcinoma, cirrhosis, and fulminant hepatitis before and after roll-out of the first pilot vaccination program against hepatitis B in Peru: An analysis of death certificate data.
    Vaccine. 2017 Jun 8. pii: S0264-410X(17)30756.
    PubMed     Text format     Abstract available


  83. CHEN MS JR, Dang JH
    What might we learn from the more successful uptake of Hepatitis B (HBV) vaccinations to increase Human Papillomavirus (HPV) vaccinations in adolescents?
    Vaccine. 2017 Jun 8. pii: S0264-410X(17)30746.
    PubMed     Text format    


  84. MARTINON-TORRES F, Boisnard F, Thomas S, Sadorge C, et al
    Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Vaccine. 2017 Jun 2. pii: S0264-410X(17)30679.
    PubMed     Text format     Abstract available


    May 2017
  85. SYED SF, Sun Y, Du T, Chen Y, et al
    Evaluation of recombinant Chinese avian hepatitis E virus (CaHEV) ORF2 and ORF3 proteins for protection of chickens against CaHEV infection.
    Vaccine. 2017 May 18. pii: S0264-410X(17)30638.
    PubMed     Text format     Abstract available


  86. DENG Y, Chuai X, Chen P, Chen H, et al
    Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30551.
    PubMed     Text format     Abstract available


  87. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available


  88. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Text format     Abstract available


    April 2017
  89. WICHGERS SCHREUR PJ, van Keulen L, Kant J, Kortekaas J, et al
    Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30498.
    PubMed     Text format     Abstract available


  90. LU PJ, O'Halloran A, Kennedy ED, Williams WW, et al
    Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30503.
    PubMed     Text format     Abstract available


  91. SIL A, Ravi MD, Patnaik BN, Dhingra MS, et al
    Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30315.
    PubMed     Text format     Abstract available


  92. SEREMBA E, Van Geertruyden JP, Ssenyonga R, Opio CK, et al
    Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30484.
    PubMed     Text format     Abstract available


  93. BREAKWELL L, Anga J, Dadari I, Sadr-Azodi N, et al
    Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30473.
    PubMed     Text format     Abstract available


  94. JIANG HY, Wang SY, Deng M, Li YC, et al
    Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30432.
    PubMed     Text format     Abstract available


    March 2017
  95. LOBAINA Y, Michel ML
    Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30366.
    PubMed     Text format     Abstract available


  96. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  97. XU B, Zhu D, Bi Y, Wang Y, et al
    Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30327.
    PubMed     Text format     Abstract available


    December 2016
  98. RISSMANN M, Ulrich R, Schroder C, Hammerschmidt B, et al
    Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31197.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: